CardioPulmonary Exercise Testing in patients with Chronic Obstructive Pulmonary Disease

Completed

• Conditions: Respiratory; Other chronic obstructive pulmonary disease; Chronic obstructive pulmonary disease (COPD)

• Registration Number: ISRCTN22314061
• Lead Sponsor: Ambulantes pneumologisches Zentrum GbR (Germany)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-05-15
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1. Diagnosis of COPD (according to American Thoracic Society [ATS] case definition) meeting all necessary criteria to be classified as Global Initiative for chronic Obstructive Lung Disease (GOLD) III and IV
2. Informed consent for study-related procedure
3. Stable medications for the last two weeks
4. Ability to safely perform the CPET without contraindications
5. Aged 18 - 80 years, both genders

Exclusion Criteria

1. Existing contraindication for exercise test
2. Patients with clinically relevant congestive heart failure or other diseases which may influence the results of the study (e.g. handicaps)
3. Exacerbation of COPD within the last two weeks before CPET
4. Conditions associated with poor compliance
5. Patients who have participated in a clinical study within the last four weeks

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Exercise variables<br>2. Lung function data<br><br>Primary and secondary outcomes will be assessed at the end of the study.

Secondary Outcome Measures

Name	Time	Method
GOLD stage, assessed at the end of the study.